发明名称 GLP-1 EXENDIN-4 PEPTIDE ANALOGS AND USES THEREOF
摘要 The invention relates to novel polypeptide analogues of GLP-1 and exendin-4. The polypeptide, in a preferred embodiment, is insulinotropic and long-acting. Preferably, the 5 polypeptide's insulinotropic effect is comparable to or exceeds the effect of an equimolar amount of GLP-1 or exendin-4. The invention also relates to a method of treating a subject with diabetes, comprising administering to the subject the polypeptide of the invention in an amount that has an insulinotropic effect. The invention also relates to methods of using GLP 1, exendin-4, and polypeptide analogues thereof for neuroprotective and neurotrophic effects. 6061765_1 (GHMatters) P52050.AU.3 LEOWNR
申请公布号 AU2014277804(B2) 申请公布日期 2016.12.01
申请号 AU20140277804 申请日期 2014.12.19
申请人 THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 发明人 GREIG, Nigel H.;EGAN, Josephine;DOYLE, Maire;HOLLOWAY, Harold;PERRY, Tracy Ann
分类号 C07K14/47;A61K38/00;A61K38/26;A61K38/28;A61P3/10;A61P9/10;A61P19/08;A61P25/00;A61P25/02;A61P25/14;A61P25/16;A61P25/28;A61P43/00;C07K14/575;C07K14/605 主分类号 C07K14/47
代理机构 代理人
主权项
地址